Bioterrorism is the most important, but not the only reason for the need to detect pathogenic spores in the air. Bacteria can also invade pharmaceutical plants, health care institutions, and food preparation zones, endangering wellness as well as life. The rapid spore detection device of this company, the stock of which is on the OTCBB exchange, therefore has many applications beyond homeland security and military installations. Investors should look for management moves with respect to this stock, which will leverage its strengths more fully than appears to be the case at this time.
The infamy of Anthrax is entirely justified, but there are hordes of bacteria, fungi, and viruses with biological warfare potentials. Any company in the detection business has to be capable of launching new products and services that offer packages of comprehensive protection. Building trust with key customer categories, and structuring alliances for sustainable cost advantages, are other drivers for success if investors are to look forward to recurring streams of returns from stocks in the pathogen detection segment. This company’s collaboration with the Jet Propulsion Laboratory (JPL) of the National Aeronautics and Space Administration (NASA) certainly gives it a head start over the competition, but investors must expect more of this kind of technological support for the company to grow within and beyond the OTCBB league.
All investors will not be impressed by the rather small size of the order the company has won from Dubai, but since the contract covers multiple threats, including ones from radiation, it could be a start of profitable horizontal diversification with key customer integration benefits. The Dubai contract also includes training in security measures, which is another encouraging sign that the company has been able to move beyond the mere assembly of a rapid spore detection device.
Let us hear your thoughts below: